Table 1 H3v-47 IgG breadth of HA binding and virus neutralization for human or swine H3N2 viruses

From: A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA

Virus

Strain

Binding EC50 (ng/mL)

Neutralization IC50 (ng/mL)

H3N2v

A/Minnesota/11/2010

4

8

Human H3N2 strains

A/Hong Kong/1/1968

>

>

A/Victoria/3/1975*

>

>

A/Bangkok/1/1979*

NT

>

A/Leningrad/360/1986*

NT

>

A/Beijing/353/1989*

NT

158

A/Shandong/9/1993*

NT

223

A/Wuhan/359/1995*

NT

127

A/Sydney/5/1997*

24

385

A/Panama/2007/1999*

20

2217

A/Fujian/411/2002*

27

578

A/New York/55/2004*

22

210

A/California/7/2004*

35

NT

A/Hiroshima/52/2005*

25

NT

A/Wisconsin/67/2005*

NT

2741

A/Brisbane/10/2007*

NT

1632

A/Perth/16/2009*

19

711

A/Victoria/361/2011*

19

1170

A/Texas/50/2012*

31

598

A/Switzerland/9715293/2013*

169

718

A/Hong Kong/4801/2014*

NT

167

Swine H3N2 strains (Cluster I–IV)

A/Swine/Texas/4199-2/98

NT

1220

A/Swine/Colorado/23619/99

NT

200

A/Swine/Oklahoma/18089/99

NT

340

A/Ohio/13/2012

NT

670

  1. NT not tested. *WHO H3N2 vaccine strain for indicated year. '>' symbol indicates values >10,000